Tempol as a potential protective agent for nucleoside reverse transcriptase inhibitor (NRTI)-induced mitochondrial toxicity

被引：0
|
作者：
Liu, Yongmin [1 ]
Liu, Yongmin [1 ]
Phuonggiang Nguyen [1 ]
Gibbons, Alexander [1 ]
Mitchell, James B. [2 ]
Poirier, Miriam C. [1 ]
机构：
[1] NCI, Carcinogen DNA Interact Sect, NIH, Bethesda, MD 20892 USA
[2] NCI, LCBG & Tumor Biol Sect, RBB, NIH, Bethesda, MD 20892 USA
来源：
MITOCHONDRION | 2012年 / 12卷 / 05期
关键词：
D O I：
10.1016/j.mito.2012.07.021
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
22
引用
收藏
页码：557 / 558
页数：2
相关论文
共 50 条
  • [31] Naringin Ameliorates HIV-1 Nucleoside Reverse Transcriptase Inhibitors-Induced Mitochondrial Toxicity
    Oluwafeyisetan, Adebiyi
    Olubunmi, Adebiyi
    Peter, Owira
    CURRENT HIV RESEARCH, 2016, 14 (06) : 506 - 516
  • [32] Development of an in ovo model for investigation of mitochondrial toxicity of nucleoside reverse transcriptase inhibitors
    Moreno, I. Garcia
    Wiertz, M.
    Hoschele, D.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 96 - 96
  • [33] Bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy®/BFTAF) in patients with baseline nucleoside reverse transcriptase inhibitor (NRTI) mutations
    Akodu, Jane
    Agyemang, Zoe
    Marshall, Gavin
    Hunter, Alan
    Simoes, Pedro
    Hart, Jennifer
    Burns, Fiona
    Barber, Tristan J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 134 - 135
  • [34] In Vitro Cross-Resistance Profile of Nucleoside Reverse Transcriptase Inhibitor (NRTI) BMS-986001 against Known NRTI Resistance Mutations
    Li, Zhufang
    Terry, Brian
    Olds, William
    Protack, Tricia
    Deminie, Carol
    Minassian, Beatrice
    Nowicka-Sans, Beata
    Sun, Yongnian
    Dicker, Ira
    Hwang, Carey
    Lataillade, Max
    Hanna, George J.
    Krystal, Mark
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (11) : 5500 - 5508
  • [35] Pyrimidine nucleoside depletion sensitizes to the mitochondrial hepatotoxicity of the reverse transcriptase inhibitor stavudine
    Setzer, Bernhard
    Lebrecht, Dirk
    Walker, Ulrich A.
    AMERICAN JOURNAL OF PATHOLOGY, 2008, 172 (03): : 681 - 690
  • [36] Mitochondrial DNA impairment in nucleoside reverse transcriptase inhibitor-associated cardiomyopathy
    Kohler, James J.
    Hosseini, Seyed H.
    Lewis, William
    CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (05) : 990 - 996
  • [37] Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors
    Rivero, Antonio
    Mira, Jose A.
    Pineda, Juan A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (03) : 342 - 346
  • [38] Interactions between non-nucleoside reverse transcriptase inhibitor and nucleoside reverse transcriptase inhibitor mutations: phenotypes and mechanisms
    Shulman, Nancy S.
    CURRENT OPINION IN HIV AND AIDS, 2007, 2 (02) : 88 - 93
  • [39] Mitochondrial oxidative stress is caused by nucleoside reverse transcriptase inhibitor (NRTI) stavudine (D4T) in HepG2 cells.
    Day, BJ
    Kovacevic, M
    Goldstein, M
    Lewis, W
    Velsor, LW
    TOXICOLOGICAL SCIENCES, 2003, 72 : 10 - 10
  • [40] Treatment of nucleoside reverse transcriptase inhibitor-induced lactic acidosis
    Brinkman, K
    Vrouenraets, S
    Kauffmann, R
    Weigel, H
    Frissen, J
    AIDS, 2000, 14 (17) : 2801 - 2802
12345